Infliximab for rheumatoid arthritis in a patient with tuberculosis [16]

New England Journal of Medicine

Volumn 355, Issue 7, 2006, Pages 740-741

  Matsumoto, Tomoshige ^a   Tanaka, Toshio ^b   Kawase, Ichiro ^b  

^a OSAKA PREFECTURAL MEDICAL CENTER FOR RESPIRATORY AND ALLERGIC DISEASES   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; INFLIXIMAB; ISONIAZID; METHOTREXATE; PREDNISOLONE; PYRAZINAMIDE; RIFAMPICIN; SALAZOSULFAPYRIDINE; TUBERCULOSTATIC AGENT; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL DISTENSION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DRUG DOSE REGIMEN; FEVER; FOLLOW UP; HUMAN; LETTER; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; RISK FACTOR; TREATMENT RESPONSE; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOUS PERITONITIS; CASE REPORT; DRUG ANTAGONISM; FEMALE; IMMUNOLOGY; MIDDLE AGED;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ANTITUBERCULAR AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; MIDDLE AGED; PERITONITIS, TUBERCULOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33747336276     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc053468     Document Type: Letter

References (4)

1. Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor-alpha neutralizing agent. N Engl J Med 2001;345:1098-104.
2. Arthritis Advisory Committee. Update on the TNF-α blocking agents. Rockville, Md.: Food and Drug Administration, 2003. (Accessed July 27, 2006, at http://www.fda.gov/ohrms/dockets/ac/03/briefing/3930B1_01_B-TNF.Briefing.doc.)
3. Taylor JC, Orkin R, Lanham J. Tuberculosis following therapy with infliximab may be refractory to antibiotic therapy. Rheumatology (Oxford) 2003;42:901-2.
4. Garcia Vidal C, Rodriguez Fernandez S, Martinez Lacasa J, et al. Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis. Clin Infect Dis 2005;40:756-9.